The Bhubaneswar Municipal Corporation (BMC) has launched the drive-in vaccination facility for the 18-44 age group and 45+ age group from June 7th to 12th.
The advisory committee “National Technical Advisory Group on Immunisation” (NTAGI), recommended that those people who have recovered from Covid-19 should take vaccine after 6 months.
Hyderabad-based Bharat Biotech has been granted permission to conduct the phase 2 and phase 3 clinical trials of its COVID-19 vaccine ‘Covaxin’ on children between the 2 to age 18.
The required statutory clearances & permissions have also been granted for this. The target has been set to start the production of Covid Vaccine by June 2022.
Odisha has received the first consignment of 1.5 lakh doses of Covaxin Covid Vaccine at 9 PM today, which will be used for the 18-44 age group in the Bhubaneswar Municipal Corporation (BMC) area.
After Covishield Covid Vaccine, which arrived in Odisha yesterday, Covaxin vaccine manufactured by Bharat Biotech, also reached Odisha. 20,000 doses of Covaxin Covid 19 vaccine arrived at the Bhubaneswar Airport, Odisha this morning.